PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-Apr-2021 Worldwide Air Quality Monitoring Industry to 2026 - Featuring Thermo Fisher Scientific, Siemens and Teledyne Technologies Among Others - ResearchAndMarkets.com Businesswire
12-Apr-2021 Philogen Announces Publication of the Construction and Application of an Innovative DNA-Encoded Chemical Library in Nature Chemistry Newswire
12-Apr-2021 Digital Pathology Analytic Market 2021 Research by Top Companies, Product Portfolio and Applications, Share, Size, Revenue, Sales Analysis Forecast 2029 MARKITWIRED
12-Apr-2021 ZOLL Medical Corporation Acquires Respicardia, Inc. Businesswire
12-Apr-2021 Urovant Sciences Announces U.S. Commercial Launch of GEMTESA® (vibegron) 75 mg Tablets for Patients with Overactive Bladder Businesswire
12-Apr-2021 Mirum Pharmaceuticals and Vivet Therapeutics Enter into Exclusive Worldwide Option and License Agreement for Vivet’s Gene Therapy Programs Targeting Progressive Familial Intrahepatic Cholestasis Businesswire
12-Apr-2021 Day One Appoints Saira Ramasastry to Board of Directors Businesswire
12-Apr-2021 OpRegen® Data Update to Be Featured at 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Presentation by Christopher D. Riemann, MD Businesswire
12-Apr-2021 Global CNS Therapeutics Industry (2020 to 2025) - Increased Spending on Prescription Drugs Bodes Well for the Market - ResearchAndMarkets.com Businesswire
12-Apr-2021 Animal Healthcare Market Analysis: The transformative Impact Due To COVID-19 MARKITWIRED
12-Apr-2021 Marinus Pharmaceuticals Bolsters Leadership Team with Two New Appointments Businesswire
12-Apr-2021 Jamestown Canyon Virus Treatment Market Analysis, Size, Share, Demand, Growth, Trends, Company Profiles and 2028 Key Regions Analysis CDN Newswire
12-Apr-2021 Precision BioSciences Appoints Stanley R. Frankel, M.D. to Board of Directors Businesswire
12-Apr-2021 Sage Therapeutics and Biogen Announce SAGE-324 Phase 2 Placebo-Controlled KINETIC Study in Essential Tremor Met Primary Endpoint Businesswire
12-Apr-2021 Taysha Gene Therapies Acquires Exclusive Worldwide Rights to Clinical-Stage AAV9 Gene Therapy Program, Now Known as TSHA-120, for the Treatment of Giant Axonal Neuropathy, a Rare and Severe Neurodegenerative Disease Businesswire
12-Apr-2021 Sensient Announces Conference Call Businesswire
12-Apr-2021 Vital Signs Monitoring Devices Market was valued at US$ 5.7 Bn in 2020, and is expected to exhibit a CAGR of 8.5% through 2030 MARKITWIRED
12-Apr-2021 Multiplex Biomarker Imaging Market Competition Landscape by Key Players, Growth Strategy, Business Opportunities, Trends and Forecast | Covid 19 Impact And Recovery MARKITWIRED
12-Apr-2021 Allergy Diagnostics Market Report- Impact Of Covid-19, Challenges, Opportunities | Highest Growth During The Forecast Period – 2021-2022 | FMI Report MARKITWIRED
12-Apr-2021 Xilio Therapeutics Strengthens Management Team with R&D Leadership Appointments Businesswire